Clinical studies recruiting near Bucharest

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Observational Study Protocol: LIVER-R
Phase N/A · Research Site · AstraZeneca · NCT06252753 Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
NA · Sana Medical Center · Philip Morris Products S.A. · NCT07108166 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · SC Memorial Healthcare International SRL · Pfizer · NCT06758401 A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Phase 3 · Prof. Dr. Alexandru Obregia Psychiatry Hospital · Bristol-Myers Squibb · NCT06929273 A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
Phase 3 · Dr. Victor Gomoiu Clinical Children Hospital · Alfasigma S.p.A. · NCT06865417 PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Phase 2 · Institutul Clinic Fundeni · Boehringer Ingelheim · NCT07355296 A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Au
Phase 3 · Local Institution - 0029 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT07424404 A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
Phase 3 · Local Institution - 0029 · Bristol-Myers Squibb · NCT07288567 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Geea Medical Easy Diet · Amgen · NCT07037433 A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
Phase 3 · Spitalul Clinic Coltea, Clinica de Hematologie · argenx · NCT06544499 A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Pati
Phase 2 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06581198 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Lotus-Med · Eli Lilly and Company · NCT06890598 Registry for Patients With Lipodystrophy
Phase N/A · C. I. Parhon National Institute of Endocrinology, Bucharest, · University of Ulm · NCT03553420 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277 A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in
Phase N/A · Institut Oncologic Prof. Dr. Alexandru Trestioreanu · Hoffmann-La Roche · NCT07284121 Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcera
Phase 3 · Spitalul Clinic Colentina · Eli Lilly and Company · NCT06937086 A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
Phase 3 · "Dr. Carol Davila" Nephrology Clinical Hospital Bucharest · UroGen Pharma Ltd. · NCT06774131 Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma
Phase 1/Phase 2 · Arensia Clinics SRL · Heidelberg Pharma AG · NCT04879043 Efficacy of INM004 in Children With STEC-HUS
Phase 3 · Spitalul Clinic de Urgenta pentru Copii Marie Sklodowska Cur · Inmunova S.A. · NCT06389474 A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone
Phase 3 · Local Institution - 0021 · Celgene · NCT05519085 DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refrac
Phase 2 · Bucharest Oncology Institute "Prof.Dr.Al. Trestioreanu" · ImmunoVaccine Technologies, Inc. (IMV Inc.) · NCT04920617 Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Phase 3 · Institutul Clinic Fundeni · Gilead Sciences · NCT06051617 A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Phase 3 · Prof. Dr. Alexandru Obregia Psychiatry Hospital · Bristol-Myers Squibb · NCT06976216 A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosc
Phase 3 · Institutul Clinic Fundeni · Boehringer Ingelheim · NCT07220083 A Phase 2 Trial to Investigate Efficacy and Safety of Vipoglanstat in Women With Endometriosis
Phase 2 · Genesys Fertility Center · Gesynta Pharma AB · NCT07260669 Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic D
Phase 2 · Site Number - 7500 · Immunovant Sciences GmbH · NCT06979531 A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate
Phase 3 · Teva Investigational Site 52149 · Teva Branded Pharmaceutical Products R&D LLC · NCT06664619 Study of SGR-1505 in Mature B-Cell Neoplasms
Phase 1 · ARENSIA Institutul Oncologic Prof. Dr. Alexandru Trestiorean · Schrödinger, Inc. · NCT05544019 A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal
Phase 3 · Delta Health Care S.R.L · Eli Lilly and Company · NCT06338995 A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung C
Phase 3 · Centrul Medical Medicover Victoria ( Site 1802) · Merck Sharp & Dohme LLC · NCT06623422

Look up another city

Look up another condition